• The decelerating age adjusted LTL attrition in cancer

  2018-10-30

  

  The decelerating age-adjusted LTL attrition in cancer cases as they approach diagnosis suggests that telomere acetylcholinesterase inhibitor mechanisms may be activated in the blood due to cancer initiation. Telomere integrity is primarily maintained by telomerase, which catalyzes the synthesis of t

• tak1 inhibitor Treatment of acquired TTP involves plasma exc

  2018-10-30

  

  Treatment of acquired TTP involves plasma exchange (PEX) to provide a new source of ADAMTS13. Steroids are used to target the autoimmune component of the disease. Therapy with rituximab reduces rates of recurrence (Scully et al., 2011; Westwood et al., 2013). Recombinant ADAMTS13 is currently underg

• From the therapeutic viewpoint the

  2018-10-30

  

  From the therapeutic viewpoint, the best and quick way to address the hurdles of controlling parasitic nematodes lies in the solid understanding of the basic biology of the organism and drawing parallels to targets of approved drugs that already have established safety profiles. This approach of rep

• An important limitation of prior biomarkers studies is that

  2018-10-30

  

  An important limitation of prior biomarkers studies is that they included all stages of RCC (Takahashi et al., 2001; Sultmann et al., 2005; Kosari et al., 2005; Jones et al., 2005; Zhao et al., 2006; Cancer Genome Atlas Research N, 2013; Brannon et al., 2010), limiting their applicability to patient

• Particulate matter was characterized in broncho alveolar lav

  2018-10-30

  

  Particulate matter was characterized in broncho-alveolar lavage fluid (BALF) extracts and in situ in AM of asthmatic Parisian children. Asthmatic patients, rather than healthy subjects, were selected for the study since fiber-optic bronchoscopy with broncho-alveolar lavage is routinely performed in

• The drug repositioning strategy in

  2018-10-30

  

  The drug repositioning strategy, in which a drug currently used for a specific disease is applied to another disease, has gained increasing attention from both academia and industry in recent years (Abbott, 2002; Rothstein et al., 2005; Bian et al., 2009; Yamamoto et al., 2013; Matsushita et al., 20

• The tumor suppressor CYLD specifically

  2018-10-30

  

  The tumor suppressor CYLD specifically digests Lys63-linked polyubiquitin chains that are attached to the TNF receptor-associated factors, TRAF2 and TRAF6, as well as an essential NF-κB signaling component, NF-κB essential modulator (NEMO) (Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki

• RG7112 The pattern of gene expression during

  2018-10-30

  

  The pattern of gene expression during the shift to reproductive senescence in the female mouse hippocampus recapitulates key observations in human AD brain tissue, specifically elevation in cPLA2, sphingomyelinase and ceramidase (Schaeffer et al., 2010; He et al., 2010; Li et al., 2014). Further, up

• Recent attention has focused on the role of

  2018-10-30

  

  Recent attention has focused on the role of vitamin D in infectious (de Haan et al., 2014) and autoimmune disease, including tuberculosis (Yang et al., 2013). In resource-limited settings, which have the largest burden of advanced HIV disease, mycobacteria are the most common pathogen involved in th

• glucocorticoid receptors The most common risk factors associ

  2018-10-30

  

  The most common risk factors associated with stroke (eg, glucocorticoid receptors failure, hypertension, diabetes, age, prior stroke) were initially identified from treatment naïve cohorts of randomised trials conducted 2 decades ago (Lip & Lane, 2015a). These trials only randomised prior stroke/TI

• The potential uses of technology

  2018-10-30

  

  The potential uses of technology in providing access to care are wide, including in older populations (Ball and Puffett, 1998) as here addressed. In fact, overall, eHealth is becoming an everyday term and is, to various degrees, permeating the lives of many. For instance, in a recent study, Salisbur

• br Type Interferonopathies and Link to

  2018-10-29

  

  Type 1 Interferonopathies and Link to T1D Type I IFNs and Type 1 IFN-Opathies: Implications for T cell Responses? As previously mentioned, T1D is historically characterized as a T-cell mediated disease. Here, we extend our discussions to suggest that the established IFN response that precedes

• Acknowled http www apexbt com media diy

  2018-10-29

  

  Acknowledgments S.O. and A.C.S were recipient of a fellowship of Consejo Nacional de Investigaciones Científicas y Técnicas (Argentina). V.B., I.E.P., E.M.V., F.C. and R.A. are members of Consejo Nacional de Investigaciones Científicas y Técnicas (Argentina). This work was partially supported by Se

• br Experimental design materials and methods The details of

  2018-10-29

  

  Experimental design, materials and methods The details of the sites have been described in our previous study [1]. In brief, the dataset collections sphingosine 1-phosphate receptor modulator localized in Kenya and Tanzania. In Kenya, was situated in Taita Hills in South-Eastern Kenya (coastal re

• br Experimental design materials and methods br Acknowledgme

  2018-10-29

  

  Experimental design, materials and methods Acknowledgments This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 44371/2014-0), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ E26/110.271/2014) and Programa Estratég

16144 records 1067/1077 page Previous Next First page 上5页 10661067106810691070 下5页 Last page